Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting akt pathway

HIGHLIGHTS

• who: December et al. from the The Ohio State University, United States have published the article: Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting Akt pathway, in the Journal: (JOURNAL)
• what: The study demonstrates that wogonin inhibits the proliferation of Pancreatic cancer cells both in_vivo and invitro. In this study, through bioinformatics analysis and experimental verification, it is showed that wogonin may enhance gemcitabine sensitivity in pancreatic cancer. This study has not been experimentally verified, and further research is needed.
• how: The experimental data were analyzed using GraphPad Prism 8.0.1 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.